Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04311788

Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial

244 patients, who have an emergency midline laparotomy for any gastrointestinal reason, will be randomized in a 1:1 ratio either to mesh group with a retrorectus prophylactic self-gripping mesh or to control group with 4:1 small stitch closure by continuous monofilament suture. They will be followed up at 30 days, 2 and 5 years to detect the incidence of incisional hernia.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jorvi Hospital, Espoo, Finland

Loading trial locations.

About this study

Incisional hernia (IH) is a common complication of abdominal wall surgery. Its' incidence varies greatly (2-30 %) among studies. The incisional hernia incidence is influenced by several factors, such as closing technique, follow-up time and the modality of radiological investigations, patient characteristics and co-morbidities as well as indication and type for surgery.

European Hernia Society (EHS) guideline strongly recommends to utilise a non-midline approach to a laparotomy whenever possible to decrease the incidence of incisional hernia. However, this is clearly not an option in an emergency laparotomy, as midline incision is the fastest and the best visualizing opening to explore the whole abdominal cavity in an emergency setting.

For elective midline incisions, evidence-based recommendation is to perform a continuous suturing technique with slowly absorbable monofilament suture when closing the incision. Suturation should be done performing a single layer aponeurotic closure technique without separate closure of the peritoneum. A small bites technique with a suture to wound length (SL/WL) ratio at least 4:1 is the current recommended method of fascial closure.

Prophylactic mesh augmentation in a non-emergency setting appears effective and safe and can be suggested for high-risk patients. However, no recommendations can be given on the optimal technique to close emergency laparotomy incisions because of lack of evidence. This problem should be emphasized on due to high rates of IH after emergency laparotomy. All this makes the use of prophylactic mesh in the emergency setting an interesting proposition, as it may decrease the rate of IHs. However, there are concerns over potential mesh related complications including infection, chronic pain, seromas and bowel fistulas especially in emergency situations like peritonitis and intestinal obstruction. There is preliminary evidence published about the safety and efficiency of the prevention of IHs using meshes in the emergency laparotomy closure even in contaminated conditions.

In the resent systematic review and meta-analysis, only results of 2 studies and altogether 299 patients were eligible for the analysis. Swiss case-control study reported an IH rate of 3,2% (2/63) in the mesh group and 28,6% (20/70) in the control group. Spanish study group had the same kind of results in their retrospective cohort; IH rate of 5,9% (3/50) in the mesh group and 33,3% (33/100) in the control group. There was no statistically significant difference in the incidence of surgical site infection or other complications when prophylactic mesh group was compared to standard closure group. SSI rate in Swiss study was 60% and respectively only 17% in the Spanish study. This may reflect differences in the patient selection, therefore the safety profile of the prophylactic mesh in the emergency setting has not been adequately described. Neither of the studies included in meta-analysis were not randomized controlled trials. There were also many methodological differences including patient selection, used mesh, and mesh placement. Thus, the conclusion of the systematic review paper was that there are limited data to assess the effect or safety of the use of prophylactic mesh in the emergency laparotomy setting. Randomized control trials are required to address this important clinical question. EHS guideline group resulted the same conclusion in their recommendation report.

There are about 1650 patients are operated in Finland because of IH every year. According to the European study, the estimated cost for IH surgery is 6450 euros. The corresponding costs in Sweden were even higher reaching 9060 euros per treatment. Extrapolated to Finland, this means that operative treatment of IHs cause more than 10 million expenses to the Finnish health care sector in a year. Some of these costs may be avoidable by using the prophylactic mesh during the closure of midline emergency laparotomies in the patients with IH risk factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Midline emergency laparotomy for any gastrointestinal indication

Exclusion criteria

  • • Previous ventral hernia repair with mesh in the midline
  • Previous inguinal or femoral hernia repair by any technique with mesh is accepted
  • Previous WHO class of physical activity 3-4 (WHO 3 more than 50% of time at rest, WHO 4 stays at rest most of the time)
  • Relaparotomy
  • Indication for laparotomy is incarcerated hernia
  • Pregnant or suspected pregnancy
  • <18 years
  • Metastastic malignancy of any origin
  • Planned osteomyelitis
  • Patients living geographically distant and/or unwilling to return for follow-ups
  • No informed consent
  • Subject participates in another RCT Intra-operative exclusion criteria applicable for both randomization groups
  • Abdomen is left open
  • Second look laparotomy planned
  • Ostomy created at the operation
  • Inability to keep the mesh securely out of the peritoneal cavity or close the anterior fascia
  • Intra-abdominal malignancy diagnosed at the operation
  • >2 cm hernia in midline

Treatment and study plan

Prophylactic self gripping mesh

Device

Prophylactic self gripping mesh, Propgrip by Medtronic.

Slowly absorbable continuous monofilament suture

Device

Fascial closure by continuous slowly absorbable 4:1 suture

Primary outcomes

  1. Incidence of incisional hernia

    Time frame: 2 years

    Incidence of incisional hernia, either symptomatic or asymptomatic detected clinically and/or radiologically

Secondary outcomes

  1. Comprehensive Complication Index

    Time frame: 30 days

    Comprehensive Complication Index

  2. Surgical site infection (SSI) rate

    Time frame: 30 days

    Surgical site infection (SSI) rate defined by CDC classification of surgical site infection

  3. Fascial rupture

    Time frame: 30 days

    Incidence of fascial rupture

  4. Incisional hernia

    Time frame: 5 years

    Incisional hernia incidence during long-term follow-up

  5. Incisional hernia repair rate

    Time frame: 5 years

    Incisional hernia repair rate during follow-up

  6. Re-operations

    Time frame: 5 years

    Re-operations due to mesh- or hernia related indications

  7. Quality of life by RAND-36

    Time frame: 5 years

    Quality of life defined by RAND-36

  8. Quality of life by Promis

    Time frame: 5 years

    Quality of life defined by Promis questionnaire

  9. Quality of life by AAS

    Time frame: 5 years

    Quality of life defined by AAS questionnaire

  10. Cost analysis

    Time frame: 5 years

    All differences in costs between the groups will be analyzed

Sponsors and collaborators

Lead sponsor

University of Oulu

Other

Collaborators

  • Helsinki University Central Hospital

Registry information

Important dates

Study start
2020
Primary completion
2025
Study completion
2028
First posted
Mar 17, 2020
Registry last updated
Feb 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.